Gallbladder Cancer | Tumor

CURE’s gallbladder cancer page is an extensive resource of cancer information featuring the latest gallbladder cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on gallbladder cancer.

GAP Triplet May Be Less Safe Than Doublet Chemo in Biliary Tract Cancer

February 24th 2025, 5:00pm

Video

An expert explains that the GAP regimen did not improve overall survival in advanced biliary tract cancer versus the doublet and increased severe side effects.

CRT and Chemo May Not Improve Survival in Resected Gallbladder Cancer

January 25th 2025, 5:43pm

Article

Among patients with resected gallbladder cancer, the addition of chemoradiation to chemotherapy treatment did not improve relapse-free survival.

Resection Volume Does Not Impact Gallbladder Cancer Survival

July 25th 2023, 9:00pm

Article

Larger liver resections do not always improve survival in patients with gallbladder cancer, recent research showed.

FDA Approves Imfinzi-Containing Regimen for Biliary Tract Cancer

September 2nd 2022, 6:26pm

Article

The Food and Drug Administration approved Imfinzi plus gemcitabine and cisplatin for locally advanced or metastatic biliary tract cancer.

Study Will Investigate If Giving Chemo Before and After Surgery Can Boost Gallbladder Cancer Outcomes

July 25th 2022, 9:00pm

Article

An ongoing clinical trial aims to determine if pre- and post-surgical chemotherapy can improve outcomes for patients with stage 2 and 3 gallbladder cancer.

Study Finds Gender Gap in Gallbladder Cancer Rates

May 4th 2017, 4:48pm

Article

Although rates of the rare, but deadly disease have been declining in men since 1973, that is not the case for women.

NORD Offers Information and Support for Patients of Rare Cancers

November 25th 2014, 2:57am

Article

NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer.